Application Sponsors
ANDA 211960 | SHILPA MEDICARE LTD | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | EQ 25MG BASE | 0 | ERLOTINIB HYDROCHLORIDE | ERLOTINIB HYDROCHLORIDE |
002 | TABLET;ORAL | EQ 100MG BASE | 0 | ERLOTINIB HYDROCHLORIDE | ERLOTINIB HYDROCHLORIDE |
003 | TABLET;ORAL | EQ 150MG BASE | 0 | ERLOTINIB HYDROCHLORIDE | ERLOTINIB HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-11-05 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
SHILPA MEDICARE LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 211960
[companyName] => SHILPA MEDICARE LTD
[docInserts] => ["",""]
[products] => [{"drugName":"ERLOTINIB HYDROCHLORIDE","activeIngredients":"ERLOTINIB HYDROCHLORIDE","strength":"EQ 25MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ERLOTINIB HYDROCHLORIDE","activeIngredients":"ERLOTINIB HYDROCHLORIDE","strength":"EQ 100MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ERLOTINIB HYDROCHLORIDE","activeIngredients":"ERLOTINIB HYDROCHLORIDE","strength":"EQ 150MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"11\/05\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-11-05
)
)